The success of copyright’s blockbuster initially drove a boom for the drug industry, however recent changes present a complicated picture for those considering a stake. Lower-cost competitors are eating into earnings, and persistent patent challenges add further complexity to the landscape. While some companies may still benefit from complementa… Read More